Olaf Wittenstein
Overview
Explore the profile of Olaf Wittenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
9
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haack L, Krug D, Domschikowski J, Wittenstein O, Rodler S, Nuhn P, et al.
Clin Transl Radiat Oncol
. 2025 Feb;
51:100918.
PMID: 39898332
Purpose: Implications of radiation dose exposure to the urethra on urinary morbidity after prostate radiotherapy are poorly understood, especially by long-term patient-reported outcomes (PRO). Therefore, our primary objective was to...
2.
Sonntag S, Wittenstein O, Blanck O, Dunst J, Huttenlocher S, Grehn M, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39857971
: Accurate target definition, treatment planning and delivery increases local tumor control for radiotherapy by minimizing collateral damage. To achieve this goal for uveal melanoma (UM), tantalum fiducial markers (TFMs)...
3.
Wittenstein O, Dunst J
Strahlenther Onkol
. 2023 Aug;
199(11):1031-1032.
PMID: 37604985
No abstract available.
4.
Wittenstein O, Krause F, Fischer M, Domschikowski J, Nitsche M, Henkenberens C, et al.
Strahlenther Onkol
. 2022 Jul;
199(3):258-267.
PMID: 35857073
Purpose: For patients with large tumors palliative radiotherapy often is the only local treatment option. To prevent toxicity the administered doses are low. Dose escalation to the tumor could be...
5.
Wittenstein O, Hiepe P, Sowa L, Karsten E, Fandrich I, Dunst J
Strahlenther Onkol
. 2019 May;
195(12):1094-1103.
PMID: 31037351
Purpose: One of the main goals in software solutions for treatment planning is to automatize delineation of organs at risk (OARs). In this pilot feasibility study a clinical validation was...